Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 120350, 9 pages
http://dx.doi.org/10.1155/2012/120350
Research Article

Molecular Mechanisms of Same TCM Syndrome for Different Diseases and Different TCM Syndrome for Same Disease in Chronic Hepatitis B and Liver Cirrhosis

1Research Center for Complex System of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China
2College of Life Science and Biotechnology, Shanghai Jiaotong University, 800 Dongchuan Road, Shanghai 200240, China

Received 9 February 2012; Revised 2 April 2012; Accepted 5 April 2012

Academic Editor: Aiping Lu

Copyright © 2012 Zhizhong Guo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Jia, W. Y. Gao, Y. Q. Yan et al., “The rediscovery of ancient Chinese herbal formulas,” Phytotherapy Research, vol. 18, no. 8, pp. 681–686, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. A. P. Lu and K. J. Chen, “Integrative medicine in clinical practice: from pattern differentiation in traditional Chinese medicine to disease treatment,” Chinese Journal of Integrative Medicine, vol. 15, no. 2, p. 152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. H. Lu, H. P. Hao, G. J. Wang, X. H. Chen, X. X. Zhu, and B. R. Xiang, “Metabolomics approach to the biochemical differentiation of Traditional Chinese Medicine syndrome types of hypertension,” Chinese Journal of Clinical Pharmacology and Therapeutics, vol. 12, no. 10, pp. 1144–1150, 2007. View at Google Scholar
  4. W. Jian, Z. Yuan, X. Huang et al., “Analysis on urine metabolomics of coronary heart disease patients with the heart blood stasis syndrome,” Journal of Traditional Chinese Medicine, vol. 51, no. 8, pp. 729–732, 2010. View at Google Scholar
  5. C. Lu, C. Xiao, G. Chen et al., “Cold and heat pattern of rheumatoid arthritis in traditional Chinese medicine: distinct molecular signatures indentified by microarray expression profiles in CD4-positive T cell,” Rheumatology International, vol. 32, no. 1, pp. 61–68, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Li, Z. Q. Zhang, L. J. Wu, X. G. Zhang, Y. D. Li, and Y. Y. Wang, “Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network,” IET Systems Biology, vol. 1, no. 1, pp. 51–60, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. WHO Media Centre and B. Hepatitis, http://www.who.int/mediacentre/factsheets/fs204.
  8. X. Cui, Y. Wang, N. Kokudo, D. Fang, and W. Tang, “Traditional Chinese medicine and related active compounds against hepatitis B virus infection,” Bioscience Trends, vol. 4, no. 2, pp. 39–47, 2010. View at Google Scholar · View at Scopus
  9. . C. Liu, Y. Hu, L. Xu, and P. Liu, “Effect of Fuzheng Huayu formula and its actions against liver fibrosis,” Chinese Medicine, vol. 4, p. 12, 2009. View at Google Scholar
  10. Z. Y. Li, X. X. Zhang, and Z. C. Xu, “Study on integrative point of traditional and western medicine—from “integrative disease and syndrome” to “integrative pathological process and syndrome”,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 25, no. 3, pp. 259–262, 2005. View at Google Scholar · View at Scopus
  11. X. Q. Li, H. Zhang, and X. W. Li, “Study on reference laboratory diagnostic index of liver-fire ascending syndrome,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 21, no. 3, pp. 190–192, 2001. View at Google Scholar · View at Scopus
  12. J. Li, “Thinking on syndrome differentiation treatment and personalized therapy for tumor,” Zhong Xi Yi Jie He Xue Bao, vol. 7, no. 4, pp. 306–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. X. X. Zeng, Z. X. Bian, T. X. Wu, S. F. Fu, E. Ziea, and W. T. Woon, “Traditional chinese medicine syndrome distribution in chronic hepatitis B populations: a systematic review,” The American Journal of Chinese Medicine, vol. 39, no. 6, pp. 1061–1074, 2011. View at Google Scholar
  14. Y. A. Ye, F. Jiang, Z. M. Zhao et al., “Chinese medical pattern distribution of chronic type hepatitis B,” Journal of Traditional Chinese Medicine, vol. 48, no. 3, pp. 256–258, 2007. View at Google Scholar
  15. P. Langfelder and S. Horvath, “WGCNA: an R package for weighted correlation network analysis,” BMC Bioinformatics, vol. 9, article 559, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Watson, “CoXpress: differential co-expression in gene expression data,” BMC Bioinformatics, vol. 7, article 509, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Y. Chen, T. L. Hwang, C. Y. Lin et al., “EMR2 receptor ligation modulates cytokine secretion profiles and cell survival of lipopolysaccharide-treated neutrophils,” Chang Gung Medical Journal, vol. 34, no. 5, pp. 468–477, 2011. View at Google Scholar
  18. C. Rancoule, J. P. Pradère, J. Gonzalez et al., “Lysophosphatidic acid-1-receptor targeting agents for fibrosis,” Expert Opinion on Investigational Drugs, vol. 20, no. 5, pp. 657–667, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. H. E. Wasmuth and R. Weiskirchen, “Pathogenesis of liver fibrosis: modulation of stellate cells by chemokines,” Zeitschrift fur Gastroenterologie, vol. 48, no. 1, pp. 38–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Liang, Z. Lu, N. Zhang, and L. Shen, “Evaluation of multi-dimensional outcomes of chronic diseases: a clinical example from China,” Archives of Gerontology and Geriatrics, vol. 52, no. 3, pp. e106–e109, 2011. View at Publisher · View at Google Scholar · View at Scopus